Biotop-report 2013

Upcoming Events 2013 - 2014

11-12 September

Workshop, Exhibition, Training Courses

6

th

 Workshop on Monoclonal Antibodies

Basel 

24-27 September

Conference, Exhibition, Training Courses

Pharmaceutical Freeze Drying Technology

Düsseldorf 

8-11 October

Conference, Exhibition, Training Courses

Pharmaceutical Cold Chain Integrity

Berlin 

4-8 November

Workshop, Conference, Exhibition, 

Training Courses

The Universe of Pre-filled Syringes 

and Injection Devices

Basel 

18-19 February

Conference, Exhibition

Microbiology Endotoxins RMM

Berlin

11-12 March

Conference, Exhibition

Parenteral Packaging

Brussels

The international non-profit organization PDA is the leading global provider of science, technology and regulatory 

information and education for the pharmaceutical and biopharmaceutical community. With more than 10,000 

members who are active in the development, manufacture, quality control and registration of medicinal products 

worldwide, our aim is to develop scientifically sound, practical technical information and resources to advance 

science and regulation for the pharmaceutical and biopharmaceutical industry as well as regulatory bodies.

PDA‘s events include conferences, meetings, and workshops held worldwide, where manufacturers, suppliers 

and scientists of the industry and governmental bodies meet to discuss major issues of mutual interest. This 

exchange of technical knowledge and expertise assist the advancement of pharmaceutical science and techno-

logy in the interest of public health.

PDA develops technical information, e.g. Technical Reports 

(www.pda.org/Publications),  comments  on  drafts  of  au-

thority guidelines, organises events like congresses, work-

shops, Interest Group Meetings and training courses.

Become a member, join committees and events, and take 

advantage  of  the  exchange  in  expertise  among  experts 

from the entire world.

Our members belong to the global players of the pharma-

ceutical  industry,  biotechnology  companies,  start-ups, 

suppliers, and authorities.

Topics include everything which is important to the manu-

facture and quality control of pharmaceutical products.

Some of the multifarious activities include process valida-

tion, monitoring, development of freeze drying cycles, GMP 

concept for gene-therapy products, virus deactivation and 

visual inspection of products.

Find  more  information  about  all  upcoming  events  on  our 

website  under  europe.pda.org  or  under  www.my-PDA.eu 

for your mobile devices.

Anzeige_VBKI.indd   1

03.06.13   10:49

---

28

BioTOPics 46 | September 2013 

BioTOP-Report

Business Location

Excellent Services for Berlin-Brandenburg

Due to its high concentration of science and research establishments, the Berlin-Brandenburg region offers out-

standing potential for technological development and cooperation. The joint Life Sciences Team from the Berlin 

Partner business development agency and the Brandenburg Economic Development Board ZAB supports the 

life sciences industry with a full range of services, including marketing activities at national and international 

exhibitions. Berlin-Brandenburg stands out in the life sciences because every segment of the health industry 

is present here. The high concentration of international excellence facilitates interdisciplinary exchange and 

makes it easier to achieve new landmark developments. At the same time, the sheer number of players can 

make it difficult to find the right partner. Our staff and colleagues at BioTOP have been in direct contact with 

the region’s companies and scientific institutions for many years and can provide quick access to the right 

contacts and potential partners.

In 2012, the Berlin Partner Life Sciences Team supported expan-

sion projects and provided location services to 22 companies in 

the capital region, which will create around 500 new jobs in the 

next three years. One of them is Takeda Pharma Vertriebs GmbH 

& Co. KG. Since autumn 2012, Takeda has been directing all its 

marketing and sales activities for the German market from Ber-

lin with some 100 employees. In addition, service functions for 

Austria and Switzerland are also centralised in Berlin. And one of 

the company’s two production sites in Germany also located in 

the capital city region: The plant in Oranienburg is a state-of-the-

art production facility for tablets, caplets and capsules with more 

than 500 employees. 

In the field of the life sciences, ZAB supported almost 70 invest-

ment and innovation projects in Brandenburg, which created 

app. 150 new jobs. The successful location of technology-based 

start-ups like OakLabs GmbH and t-cell Europe GmbH deserves 

particular mention. The joint acquisition team with Berlin Partner 

arranged the location of Analytica Alimentaria GmbH in Klein-

machnow, while a further direct investment supported by the 

team concerns the company plusBlut GmbH in Hennigsdorf.

In 2012, the region was represented with its own booths at four 

important international fairs. The aim was to position the region’s 

companies on the global markets and present the cluster of the 

healthcare industries in Berlin-Brandenburg – HealthCapital – as 

one of Europe‘s leading health sector locations.

Berlin Partner also organised an information booth at BIO 2012 

in Boston and BIO 2013 in Chicago. As in the years before, the 

Berlin-Brandenburg Night was held on the opening day of BIO. 

Bayer Healthcare acted as the lead sponsor once again. Both 

events attracted some 400 international guests from biotechnol-

ogy and pharmaceutical companies, which followed the invita-

tion from HealthCapital and Bayer HealthCare.

Carolin Clement

Head of Unit Biotech I Pharma

Berlin Partner for Business and Technology

Phone: [phone] 

[e-mail]

www.berlin-partner.de

Dr. Ute Hartmann

Head of Department Healthcare Industry/Life Sciences

Brandenburg Economic Development Board (ZAB)

Phone: [phone]

[e-mail]

www.zab-brandenburg.de

---